Sunday, June 20, 2021
ADVT 
International

UN: 'Concerning news' vaccines may not work against variants

Darpan News Desk The Canadian Press, 08 Feb, 2021 06:54 PM
  • UN: 'Concerning news' vaccines may not work against variants

The head of the World Health Organization said Monday the emergence of new COVID-19 variants has raised questions about whether or not existing vaccines will work, calling it “concerning news” that the vaccines developed so far may be less effective against the variant first detected in South Africa.

Tedros Adhanom Ghebreyesus said at a media briefing that South Africa’s decision on Sunday to suspend its vaccination campaign using the AstraZeneca vaccine is “a reminder that we need to do everything we can to reduce circulation of the virus with proven public health measures.”

He said it was increasingly clear that vaccine manufacturers would need to tweak their existing shots to address the ongoing genetic evolution of the coronavirus, saying booster shots would most likely be necessary, especially since new variants of the virus are now spreading globally and appear likely to become the predominant strains.

Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine. That designation would allow millions of doses to be shipped to poor countries as part of a U.N.-backed effort to distribute COVID-19 vaccines worldwide known as COVAX.

Last week, Tedros said that more than three quarters of COVID-19 vaccines had been administered in just 10 countries and that immunization in nearly 130 countries had yet to start. Despite WHO's aim of starting COVID-19 vaccination in poor countries at the same time as wealthy countries, COVAX hasn't delivered any vaccine doses anywhere.

Dr. Soumya Swaminathan, WHO's chief scientist, said people shouldn't conclude from South Africa's decision that the AstraZeneca vaccine doesn't work. She said all of the available evidence to date shows the vaccines developed so far reduce deaths, hospitalizations and severe disease.

Other COVID-19 vaccines developed by Novavax, Pfizer and BioNTech and Johnson & Johnson also appear to be less effective against the strain first identified in South Africa, although they may prevent severe disease.

MORE International ARTICLES

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?

Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings

Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper

The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US

Some of Trump's trade legacy to linger under Biden

Some of Trump's trade legacy to linger under Biden

Future administrations, be they Democrat or Republican, are unlikely to forget the lessons of 2016 any time soon, a panel of trade experts agreed Thursday.

Some of Trump's trade legacy to linger under Biden